Opendata, web and dolomites

NanoMop SIGNED

Smart Cholesterol-Mopping Polymer Nanoparticles in Niemann-Pick Disease Type C

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NanoMop project word cloud

Explore the words cloud of the NanoMop project. It provides you a very rough idea of what is the project "NanoMop" about.

networking    disorder    bcds    naturally    carry    diversify    urgently    threatening    treatment    pursue    complications    cds    decade    progress    life    incidence    caused    training    sugars    independent    players    health    pharmacokinetics    position    interdisciplinary    poor    area    brain    polymer    accumulation    skillset    smart    me    designed    bcd    academic    therapeutic    gained    broaden    disease    successful    mobility    create    pick    cognitive    question    reaching    professionally    class    techniques    niemann    modification    overcome    stakeholders    recognised    sectoral    npc    cyclodextrins    capacity    occurring    fellowship    industrial    researcher    chemical    completion    alzheimer    puts    considerable    competences    therapies    family    decline    personally    cutting    subsequent    charity    nanomops    horizon2020    suffers    macromolecular    bioavailability    answered    limitations    significantly    edge    successfully    career    genetic    cholesterol    biological    excellent    nanoparticles    detected    chemistry    inter    intervention    people    internationally    profile    sequester    childhood    rare    international    line   

Project "NanoMop" data sheet

The following table provides information about the project.

Coordinator
ISTANBUL TEKNIK UNIVERSITESI 

Organization address
address: AYAZAGA KAMPUSU
city: MASLAK ISTANBUL
postcode: 34469
website: www.itu.edu.tr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Turkey [TR]
 Total cost 145˙845 €
 EC max contribution 145˙845 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ISTANBUL TEKNIK UNIVERSITESI TR (MASLAK ISTANBUL) coordinator 145˙845.00

Map

 Project objective

Niemann-Pick Disease Type C (NPC), also known as “childhood Alzheimer’s”, is a rare genetic disorder caused by the accumulation of cholesterol particularly in the brain with subsequent cognitive and mobility decline. In the EU NPC has an incidence of 1 per 100,000 people. Most cases are detected during childhood and progress to cause life-threatening complications by the second or third decade of life. Cyclodextrins (CDs), a family of naturally occurring sugars, have recently gained considerable attention as a potential therapeutic intervention in the treatment of the disease because of their capacity to sequester cholesterol. Although promising, the current treatment of NPC based on a chemical modification of bCD suffers from poor pharmacokinetics and bioavailability in the brain. In this project I propose a new interdisciplinary approach in which bCDs will be embedded into a novel class of smart polymer nanoparticles (NanoMops) that could overcome these limitations. The project addresses an important question that needs to be answered urgently and its successful completion will contribute to the treatment of the neglected disease in line with the Horizon2020 health goal of providing better and more effective therapies. My specific skillset in chemical modification of CDs puts me in a unique position to successfully carry out this project. This interdisciplinary proposal is designed to provide me with advanced training in macromolecular chemistry and in a range of cutting-edge biological techniques. The fellowship will significantly diversify my competences and broaden my profile – professionally and personally - enabling me to pursue a career as an internationally recognised independent researcher. The project will also create new important international and inter-sectoral partnerships with excellent academic and industrial players while reaching out to charity organisations, raising awareness and networking researchers and key stakeholders in the area of NPC.

 Publications

year authors and title journal last update
List of publications.
2019 Antonino Puglisi, Ece Bayir, Suna Timur, Yusuf Yagci
pH-Responsive Polymersome Microparticles as Smart Cyclodextrin-Releasing Agents
published pages: 4001-4007, ISSN: 1525-7797, DOI: 10.1021/acs.biomac.9b01083
Biomacromolecules 20/10 2019-10-30
2019 Antonino Puglisi, Yusuf Yagci
Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C
published pages: 1800557, ISSN: 1022-1336, DOI: 10.1002/marc.201800557
Macromolecular Rapid Communications 40/1 2019-09-26

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOMOP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOMOP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RipGEESE (2020)

Identifying the ripples of gene regulation evolution in the evolution of gene sequences to determine when animal nervous systems evolved

Read More  

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

MacMeninges (2019)

Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging

Read More